Natural hormone therapy for menopause.

Area of Science:

• Endocrinology
• Women's Health
• Pharmacology

Background:

• Menopausal women experience deficiencies in key hormones like estrogen, progesterone, testosterone, and DHEA.
• Traditional hormone replacement therapy (HRT) using equine estrogen and medroxyprogesterone is associated with increased risks of cardiovascular events, stroke, dementia, and breast cancer.
• Bio-identical hormones, chemically identical to endogenous hormones, are increasingly popular but lack extensive published data.

Purpose of the Study:

• To evaluate the efficacy and safety of bio-identical hormone replacement therapy (HRT) in menopausal women.
• To assess symptom control, including mental symptoms and weight changes, in patients receiving natural estrogen and progesterone with or without DHEA or testosterone.
• To compare the safety profile of bio-identical HRT with traditional HRT.

Main Methods:

• A 12-month follow-up study involving 189 menopausal patients.
• Administration of natural estrogen plus progesterone, with optional DHEA or testosterone, based on a defined protocol.
• Monitoring of symptom control, mental health improvements, weight changes, and adverse events.

Main Results:

• Ninety-seven percent of patients reported symptom control, with 90% experiencing improvement in mental symptoms.
• Sixty percent of patients who had gained weight lost an average of 14.8 lbs.
• No complications associated with traditional HRT were observed in the study group.

Conclusions:

• Bio-identical hormone therapy, using natural estrogen and progesterone with or without DHEA/testosterone, demonstrates high efficacy in managing menopausal symptoms.
• This therapeutic approach appears to be safe, with no observed adverse events linked to traditional HRT.
• Larger, controlled trials are warranted to further validate these findings and establish optimal protocols for bio-identical HRT in menopause management.